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Abstract
Background: Influenza causes yearly seasonal epidemics and periodic pandemics. Global systems have been established to
monitor the evolution and impact of influenza viruses, yet regional analysis of surveillance findings has been limited. This
study describes epidemiological and virological characteristics of influenza during 2006–2010 in the World Health
Organization’s Western Pacific Region.
Methodology/Principal Findings: Influenza-like illness (ILI) and influenza virus data were obtained from the 14 countries
with National Influenza Centres. Data were obtained directly from countries and from FluNet, the web-based tool of the
Global Influenza Surveillance and Response System. National influenza surveillance and participation in the global system
increased over the five years. Peaks in ILI reporting appeared to be coincident with the proportion of influenza positive
specimens. Temporal patterns of ILI activity and the proportion of influenza positive specimens were clearly observed in
temperate countries: Mongolia, Japan and the Republic of Korea in the northern hemisphere, and Australia, New Zealand,
Fiji and New Caledonia (France) in the southern hemisphere. Two annual peaks in activity were observed in China from 2006
through the first quarter of 2009. A temporal pattern was less evident in tropical countries, where influenza activity was
observed year-round. Influenza A viruses accounted for the majority of viruses reported between 2006 and 2009, but an
equal proportion of influenza A and influenza B viruses was detected in 2010.
Conclusions/Significance: Despite differences in surveillance methods and intensity, commonalities in ILI and influenza
virus circulation patterns were identified. Patterns suggest that influenza circulation may be dependent on a multitude of
factors including seasonality and population movement. Dominant strains in Southeast Asian countries were later detected
in other countries. Thus, timely reporting and regional sharing of information about influenza may serve as an early warning,
and may assist countries to anticipate the potential severity and burden associated with incoming strains.
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Introduction
Influenza, an acute viral infection characterised by fever with
cough and/or sore throat, occurs as annual seasonal epidemics in
winter or early spring in countries with temperate climates [1].
These yearly epidemics pose a substantial health burden arising
from related complications such as lower respiratory tract
infections and exacerbation of cardiopulmonary and other chronic
diseases. Influenza burden in tropical or subtropical countries is
not well-defined, although there is mounting evidence that
prevalence and excess mortality from influenza are comparable
to those seen in temperate countries [2,3].
The Global Influenza Surveillance Network (GISN) was
established by the World Health Organization (WHO) in 1952
and was re-named the Global Influenza Surveillance and
Response System (GISRS) in 2011 [4]. The GISRS monitors
the impact and evolution of influenza viruses and emergence of
novel influenza viruses with pandemic potential. It also provides
recommendations on suitable virus strains for inclusion in vaccines
(twice yearly for northern and southern hemisphere seasons) and
on diagnostic tests and antiviral drug sensitivity. The GISRS
currently consists of six WHO Collaborating Centres (WHO CCs)
for Reference and Research on Influenza (five for human
influenza and one for animal influenza), four Essential Regulatory
Laboratories (ERLs) and 136 WHO National Influenza Centres
(NICs) in 106 WHO Member States.
The WHO’s Western Pacific Region includes 37 countries and
areas that span from the northern hemisphere through the tropics
to the southern hemisphere (Figure 1). This region covers nearly
one-quarter of the world’s population with approximately 1.6
billion people. The GISRS in the region currently consists of 21
NICs in 15 countries, three WHO CCs, one each in Australia,
Japan and China, and two ERLs, in Australia and Japan.
Progress that has been made in the development of influenza
surveillance capacity in the Western Pacific Region was demon-
strated by the rapid availability of data from 34 countries and
areas during the influenza A(H1N1)pdm09 pandemic [5].
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virological data on seasonal influenza in the region [6]. This study
describes the epidemiological and virological characteristics of
influenza for 2006–2010 in the Western Pacific Region, with a
view to supporting the development of future regional strategies
and workplans to further strengthen influenza programmes.
Methods
Data Collection
Influenza-like illness (ILI) and influenza virus data for 2006–
2010 were obtained from the 14 countries with National Influenza
Centers (NICs) in the Western Pacific Region that participated in
the Fifth Meeting of NICs in WHO’s Western Pacific and South-
East Asia Regions in June 2011. Participating countries included
Australia, Cambodia, China (including Hong Kong), Fiji, New
Caledonia (France), Japan, Lao People’s Democratic Republic
(PDR), Malaysia, Mongolia, New Zealand, the Philippines, the
Republic of Korea, Singapore, and Viet Nam (Figure 1). Data
were obtained from NICs and disease surveillance units with
support of WHO country offices.
Data were collected using an email survey between April and
October 2011. The survey included a questionnaire that
ascertained qualitative data on ILI surveillance systems, case
definitions applied and virological surveillance methods. The
email survey also obtained data on number of weekly or monthly
ILI cases reported and total number of consultations for any cause
by age group. Age groups were categorized as 0 to ,2 years, 2 to
,5 years, 5 to ,18 years, 18 to ,65 years, and $65 years;
however, alternative age groupings were accepted to allow for
reporting differences by countries. These data were obtained using
a reporting template developed in Microsoft ExcelH.
Virological data were initially extracted from FluNet, the web-
based data collection and reporting tool of the GISRS, to which
NICs report the number of specimens processed for influenza virus
testing and the number testing positive for influenza
A(H1N1)pdm09, seasonal A(H1), A(H3), A(H5), A(not subtyped),
B(Victoria), B(Yamagata) or B(lineage not determined). The
extracted data were sent electronically to each participating
country in March 2011 for confirmation. Using the above-
mentioned Microsoft ExcelH template, virological data by week
were also requested from countries that had not reported to
Figure 1. WHO’s Western Pacific Region with National Influenza Centres and WHO Collaborating Centres on influenza, and years of
ILI data contributed by each country/area.
doi:10.1371/journal.pone.0037568.g001
Seasonal Influenza in the Western Pacific Region
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37568FluNet or had data missing in FluNet during 2006–2010. See
Supplementary Table S1 for the type and period of data available
from each country participating in this study.
Data Analysis
ILI case definitions and surveillance systems were tabulated for
each reporting country.
For data presentation and comparison, the raw data were
tabulated and graphed, and countries were grouped according to
geographic location and apparent similarities in ILI and virus
circulation patterns. The groups are: (A) the Republic of Korea
and Mongolia, (B) China, (C) Cambodia, Lao PDR, Malaysia,
Philippines, Singapore and Viet Nam, and (D) Australia, Fiji, New
Caledonia (France) and New Zealand. Percent ILI was calculated
as a proportion of ILI cases per total consultations, and percent
specimens positive for influenza was calculated as a proportion of
influenza positive specimens per total specimens submitted for
influenza testing. For each group of countries, the denominators
(total consultations or total specimens tested) were first summed
and then used to calculate regional proportions. Ratios for ILI
cases and ratios of specimens positive for influenza could not be
calculated for Japan, as denominators were not reported in the
data collection template, thus it was not included in any of the
groups. Case and specimen numbers were described in the results
text.
Results
Fourteen countries responded to the survey. ILI case definitions,
surveillance approach and intensity varied across countries, as did
the number of years of reporting.
The definition of ILI varied across sentinel surveillance schemes
within countries and areas and across countries (Table 1). Seven
countries and one area reported applying the WHO definition: a
person with sudden onset of fever .38uC and cough or sore throat
in the absence of other diagnoses. Other definitions applied by
reporting countries used broader clinical symptoms, separated
definitions for different age groups or limited the timeframe for
onset of different symptoms.
All 14 countries reported using a sentinel site approach for
influenza surveillance (Table 1). The number and type of sites
varied widely across countries and areas, and some countries
incrementally increased the number of surveillance sites during
2006–2010, especially in response to the A(H1N1)pdm09
pandemic. Confirmatory testing of a proportion of ILI cases was
conducted through the surveillance systems. The number of
specimens collected by surveillance schemes varied within and
across countries and areas. Data were not collected on methods for
selecting cases for specimen collection.
During the study period, 1,070,792 influenza virus detections
were reported to FluNet globally, of which 301,195 (28%) were
reported from NICs in the Western Pacific Region (Figure 2).
Within the Western Pacific Region, China contributed the most
data for virus detections (57%), followed by Japan (19%) and the
Republic of Korea (7%).
The number of Western Pacific Region countries submitting
virus information to FluNet and the reported number of specimens
tested for influenza increased over the five-year study period
(Table 2). From 2006 through 2008, an average of 84,105
specimens was tested each year (range: 65,103 to 94,274). In 2009,
the number of specimens tested increased to 366,164, a 4.3-fold
compared to the average tested in the previous three years, and
remained elevated in 2010. Of the total 926,064 specimens tested
throughout the study period, 21.2% (n=196,720) were influenza
positive. From 2006 through 2008, the weighted average
proportion of specimens found positive for influenza was 11.7%
(range: 11.4% to 12.0%). The overall proportion of specimens
found positive for influenza increased 2.7-fold to 31.6% in 2009
compared to the 2006–2008 average, but decreased to 16.8% in
2010.
Influenza A viruses accounted for the majority of viruses
reported between 2006 and 2009, but an equal proportion of
influenza A and influenza B viruses was detected in 2010. By
subtype or lineage, a large proportion of viruses reported were
seasonal A(H1) (40%) and B (lineage not determined) (30%) in
2006. This changed in 2007 when 48% of all influenza positive
specimens were A(H3), which continued to be commonly detected
in 2008 (18%) along with a resurgence of seasonal A(H1) viruses
(38%).
In 2009, 64% of all viruses reported were A(H1N1)pdm09.
Other viruses detected in 2009 were A(H3) (16%) and A(not
subtyped) (10%), but very few influenza B viruses were reported.
However, there was an increase in influenza B(lineage not
determined) reports in 2010 (39% of all viruses reported) along
with frequent detection of the A(H1N1)pdm09 and A(H3).
B(Victoria) was reported more frequently than B(Yamagata) in
2006, 2009 and 2010 but less frequently in 2007 and 2008.
ILI case numbers and total all-cause consultations were
provided by 10 of the 14 countries in this study. Australia, China
(including Hong Kong), the Republic of Korea, Malaysia,
Mongolia and Viet Nam provided data for the five year study
period. New Zealand provided aggregate data for the five years,
and was analyzed separately. Japan provided the total number of
ILI cases but not the total number of all-cause consultations for the
study period, and was also analyzed separately. Lao PDR provided
ILI data for three years (2008–2010) and Cambodia, the
Philippines and Singapore provided ILI data for two years
(2009–2010) (Figure 1). Data for total specimens tested and
number positive for influenza were available for all countries
except Japan, where only the number of specimens positive for
influenza was provided.
Over the five year period, peaks in ILI reporting appeared to be
coincident with the proportion of specimens positive for influenza
(Figure 3). This was particularly evident for the northern and
southern hemispheres (Panels A & D, Figure 3).
A yearly seasonal pattern typical of temperate northern
hemisphere countries was observed in the Republic of Korea
and Mongolia (Panel A, Figure 3), where peaks in ILI activity were
detected in January-March each year. A similar seasonal pattern
was observed in Japan, where the reported number of ILI cases
and the number of specimens positive for influenza were greatest
in the first three months of each year (data not shown). A seasonal
pattern typical of temperate southern hemisphere countries was
observed in Australia (Panel D, Figure 3), where ILI activity and
specimens positive for influenza peaked in July-September each
year. A similar pattern was observed in New Zealand where ILI
activity peaked approximately five weeks earlier than it did in
Australia each year (data not shown). Two annual peaks in activity
were observed in China (Panel B, Figure 3), one in January and
one in July or August, from 2006 through 2008 and prior to the
appearance of influenza A(H1N1)pdm09 in 2009. A temporal
pattern was less evident in the group of six other reporting
countries (Panel C, Figure 3).
ILI activity and the proportion of specimens positive for
influenza were greater during July through December 2009
compared to previous years. This was observed in all reporting
countries except Australia, where peak ILI activity in 2009 was of
similar magnitude to previous years.
Seasonal Influenza in the Western Pacific Region
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region were influenza B and seasonal A(H1) and influenza B and
influenza A(H3), respectively. Influenza B was identified through-
out this period, seasonal A(H1) was frequently identified in May
through August 2006 and A(H3) detection increased in January
through August 2007. This was followed by detection of A(H3) in
Australia, Fiji, New Zealand and New Caledonia (France) in June
through September 2007 (Panel D, Figure 4). Only influenza B
and A(not subtyped) were detected in Mongolia and the Republic
of Korea during the same time period.
In 2008, influenza B was most frequently reported by countries
in the region. However, in the latter half of 2008 an increase in
seasonal A(H1) was seen in China (Panel B, Figure 4), Japan (data
not shown), Mongolia and the Republic of Korea (Panel A,
Figure 4). Seasonal A(H1) viruses were reported from Mongolia
from December 2008 through February 2009, but did not
predominate among influenza viruses reported by other countries
in the Western Pacific Region during 2008 (Panels C and D,
Figure 4).
In 2009, pandemic A(H1N1)pdm09 was predominant in the
region. A(H3) viruses were reported from all countries in the
region, and peaked earliest in Japan, Mongolia and the Republic
of Korea, followed by all other countries except China which saw
a later A(H3) peak in August through September. Australia, the
Philippines and Singapore were the first countries to report
detection of the pandemic A(H1N1)pdm09 subtype to FluNet in
May 2009 (although New Zealand was the first country in the
region to detect this virus). The dominance of this virus in the
Table 1. Surveillance and ILI case definitions in Western Pacific Region countries, 2006–2010.
Country Surveillance System ILI Case definition
Australia* Approximately 250 general practitioner clinics Fever ($38uC), cough and fatigue
65 Emergency departments Emergency Departments: Fever ($38uC) or
feverishness plus at least one of the following
respiratory symptoms: cough or
sore throat
Community online data collection Cough and fever
Cambodia 8 hospitals Sudden onset of fever of .38uC and cough or
sore throat within 5 days
China 2006–2009: incremental increase from 197 to 556 sentinel hospitals and
411 network laboratories
Sudden onset of fever of .38uC and cough or sore
throat
2010: 556 sentinel hospitals and 411 network laboratories As above
Hong Kong (China) Approximately 114 public and private outpatient clinics WHO definition
‘
Fiji January-June 2009: 7 sentinel hospitals WHO definition
‘
July 2009–December 2010: 13 sentinel hospitals As above
Japan 3,000 pediatric and 2,000 internal medicine sites Sudden onset of fever of .38uC, Upper respiratory
infection and feeling tired.
Lao PDR 2007–2008: 3 hospitals WHO definition
‘
2009–2010: 8 hospitals As above
Malaysia All government health clinics (approximately 600) WHO definition
‘
Mongolia 2006–2009: incremental increase from 30 hospitals and health centres to
37 hospitals and 121 health centres
WHO definition
‘
2010: 37 hospitals and 121 health centres As above
New Caledonia (France) 2 hospitals and 7 health centres Sudden onset of fever $38uC (or shiver if
temperature not available) and cough (or sore
throat)
New Zealand 2006–2008, 2010: Approximately 101 sentinel general practitioners operating
May-September
An acute respiratory tract infection with abrupt
onset of at least two of the following: fever, chills,
headache and myalgia
2009: Approximately 101 sentinel general practitioners operating May-December
(due to pandemic)
As above
Philippines 59 health centres and hospitals Fever of .38uC and cough or sore throat. For
children #3 years, fever of .38uC and cough,
sore throat or runny nose
Republic of Korea Approximately 800 sentinel sites WHO definition
‘
Singapore 18 government clinics and 98 general practitioner clinics WHO definition
‘
Viet Nam:
Hanoi 2006–2010: 15 sentinel hospitals WHO definition
‘
Ho Chi Minh City 2006: 3 sentinel hospitals WHO definition
‘
2007–2010: 5 sentinel hospitals As above
*Laboratory-confirmed cases of influenza are nationally notifiable.
‘WHO definition: A person with sudden onset of fever of .38uC and cough or sore throat in the absence of other diagnoses.
doi:10.1371/journal.pone.0037568.t001
Seasonal Influenza in the Western Pacific Region
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May to August 2009 in Cambodia, Lao PDR, Malaysia,
Philippines, Singapore and Viet Nam, July to August 2009 in
Australia, Fiji, New Zealand and New Caledonia (France), and
October 2009 to January 2010 in China, Mongolia and the
Republic of Korea. Japan had dual peaks of pandemic virus
detection, with a large number of detections in August to
September 2009 followed by resurgence in November to January
2010 (data not shown).
During the pandemic period (11 June 2009 to 10 August 2010),
other influenza A virus sub-types, including A(H3), were reported.
There was also resurgence of influenza B activity with peaks in
China, Mongolia and the Republic of Korea during January to
April 2010, followed by the remaining countries in July to
September 2010 (Figure 4).
Six countries reported data by age group for ILI cases and total
consultations: Cambodia (2009–2010), Lao PDR (2008–2010),
Mongolia (2006–2010), New Zealand (2006–2010), the Philippines
(2009–2010) and Viet Nam (2008–2010). Cambodia, Mongolia
and New Zealand reported greater ILI activity in the 0–5 years
age group than other age groups (5 to ,18, 18 to ,65, and 65
years and over, data not shown). The Philippines and Lao PDR
reported greater ILI activity in the 0 to ,5 and 5 to ,18 age
groups, while Viet Nam reported greater ILI activity in the 5 to
,18 and 18 to ,65 age groups (data not shown).
Figure 2. Proportion of influenza specimens reported by Western Pacific Region countries to GISN, 2006–2010
‘.
‘ The proportion of
contribution of viruses reported to FluNet from NICs in the Western Pacific Region ranged from 25–43% during 2006–2010. * Other: Viet Nam,
Mongolia, New Zealand, Cambodia, Malaysia, New Caledonia (France), Fiji and Lao PDR.
doi:10.1371/journal.pone.0037568.g002
Table 2. Specimens tested and specimens positive for influenza by type/subtype/lineage in Western Pacific Region countries,
2006–2010.
‘
20066 2007
1 2008
2 2009
3 2010
3
Number of specimens tested 65,103 92,939 94,274 366,164 307,584
Number of influenza positive specimens 7,425 (11.4%) 11,143 (12.0%) 11,025 (11.7%) 115,554 (31.6%) 51,573 (16.8%)
Influenza positive specimens by type/subtype
Influenza A total 4,393 7,297 7,426 110,668 26,008
A(H1) 2,952 907 4,241 6,307 31
A(H1N1)pdm09 0 0 0 74,252 10,728
A(H3) 918 5,397 1,961 19,018 12,276
A(subtyping not performed) 523 993 1,224 11,091 2,973
Influenza B total 3,032 3,846 3,599 4,886 25,565
B(Victoria) 744 927 827 1,532 4,505
B(Yamagata) 76 1,642 1,360 235 954
B(lineage not determined) 2,212 1,277 1,412 3,119 20,106
uData from Australia, Cambodia, China, Malaysia, Mongolia, New Caledonia (France), New Zealand, Philippines, and Viet Nam.
1Data from the countries with data in 2006 plus Singapore.
2Data from the countries with data in 2007 plus the Republic of Korea and Lao PDR.
3Data from the countries with data in 2008 plus Fiji.
doi:10.1371/journal.pone.0037568.t002
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Influenza was prevalent in all countries and areas that
participated in this study, which included countries and areas in
temperate parts of the northern and southern hemispheres and
countries and areas in the tropics. Despite differences in
surveillance approaches, methods and intensity, commonalities
in disease and virus circulation patterns were identified.
The seasonal pattern of influenza activity observed in Mongolia
and the Republic of Korea in the northern hemisphere is
consistent with a previous report from Mongolia [7]. Similarities
in seasonality were also observed amongst Australia, Fiji, New
Caledonia (France) and New Zealand in the southern hemisphere.
Other countries in the region had less discernable seasonal
patterns with influenza activity occurring throughout the year,
which is aligned with previous research findings and generally
consistent with their location in the tropics [6,8,9,10]. Although
Fiji and New Caledonia (France) are tropical, their influenza
circulation patterns appeared to be more aligned with Australia
and New Zealand than other tropical countries in the region. This
highlights that influenza circulation may be dependent on a
multitude of factors including seasonality and people movement
pathways. Patterns of disease may also vary within countries, such
as China where research suggests that seasonal patterns and peaks
of influenza activity differ between the northern and the southern
parts of the country [9].
Detection of A(H3) in Australia and New Zealand in mid-2007
was preceded by frequent detection of the virus in Cambodia,
China, Lao PDR, Malaysia, the Philippines, Singapore and Viet
Nam in early 2007. This supports the hypothesis that dominant
strains in East and Southeast Asian countries spread to other
countries in the region [11,12,13,14]. Similarly, the dominance of
former seasonal A(H1) in Mongolia and the Republic of Korea in
December 2008 to February 2009 was preceded by dominance of
this subtype in China in mid-2008. In the future, timely reporting
and regional sharing of influenza virus information may serve as
an early warning, and may assist countries to anticipate the
potential severity and burden associated with incoming influenza
strains. One example of this in practice is in the Federated States
of Micronesia which has utilized the influenza surveillance findings
from Guam for early warning (personal communication). Efforts
are ongoing within GISRS in the region to increase timely
reporting and regional sharing of influenza virus information to
maximize the utility of these surveillance systems.
This study included data on the influenza A(H1N1)pdm09
pandemic, providing the opportunity to assess changes in patterns
of influenza activity during and after this outlier event. The novel
A(H1N1)pdm09 virus was first detected in Mexico in April 2009.
Despite rapid spread to the Western Pacific Region, pandemic
virus activity peaked in the temperate countries during their
typical annual influenza seasons: the winter months in Australia
and New Zealand (July to September) and in Japan, Mongolia and
the Republic of Korea (November to January). Even though this
virus dominated epidemiological patterns in 2009 to 2010, other
types/subtypes of influenza co-circulated at low levels during the
pandemic period throughout the region [15]. The epidemiological
characteristics of the pandemic in the region have been described
previously [5].
Overall, temporal patterns of influenza activity appeared to be
coincident between ILI syndromic surveillance and virological
surveillance. This highlights the utility of combining data from ILI
surveillance with virological surveillance for interpreting influenza
activity. Virological surveillance adds specificity to the overall
influenza surveillance program, informs vaccine strain selection at
the global level and enables prompt detection of antigenic,
genomic and drug-sensitivity changes in the virus. An example of
the latter was the detection of increased antiviral drug resistance
among seasonal A(H1) strains in 2008 [16]. This highlights the
importance of timely reporting into these surveillance systems,
including FluNet, so that virus detection is synchronized with
disease activity and controls measures.
This study highlighted that regional participation in global
virological surveillance systems has been high. Of the 34 different
virus strains recommended by WHO for use in influenza vaccines
between 1988 and 2010, 26 (76.4%) were developed from isolates
from this region [17]. Participation increased during the study
period as evidenced by the addition of three NICs, one each in
Cambodia, Lao PDR and Viet Nam, and one WHO Collaborat-
ing Centre in China. There was also an increase in the number of
sentinel surveillance sites in some countries.
This study had a number of limitations. A key limitation of the
study is that the data are aggregated across countries, over time
and age groups. This limits the type of analyses and inferences
made about the data. Since data aggregation can result in
reporting bias, we have tried to reduce the risk of bias through the
involvement of authors from all countries participating in the
study. Authors from each country were tasked with ensuring that
the analyses and interpretation were in line with their national-
level context and conclusions.
Reporting countries and areas applied different case definitions,
as well as different methodologies for data collection and sampling,
and some incrementally added surveillance sites or changed
surveillance methods or testing methods. These differences limited
the ability to make comparisons and draw conclusions, especially
for the magnitude of disease activity and representativeness of the
surveillance systems.
Use of different ILI case definitions impacts disease prevalence
comparisons, where some definitions may be more sensitive than
others in case-ascertainment. Even though the ILI case definitions
used by the 14 reporting countries appear relatively similar, the
impact of the differences on the magnitude of disease activity was
not assessed. This is an area of future work. It may be argued that
consistent use of different case definitions over time still enable
comparison of disease trends. However, in this study, the data
collection tool did not assess whether countries changed their ILI
case definitions during the five year period (2006–2010). Again,
this necessitates further research to determine whether case
definitions have changed over time and the impact changes may
have had on reported ILI trends.
Although the data collection tools included disaggregation by
age groupings, the available data was too limited to do summary
analyses. In addition, not all influenza surveillance information in
the region was captured. For example, countries and areas without
NICs in the Pacific also contribute virus data to the international
influenza surveillance systems by submitting samples to reference
Figure 3. Proportion of specimens positive for influenza and proportion of consultations meeting ILI case definition in Western
Pacific Region countries, 2006–2010.*
‘ *Panel A: Mongolia and Republic of Korea; Panel B: China; Panel C: Cambodia, Lao PDR, Malaysia,
Philippines, Singapore, and Viet Nam; and Panel D: Australia, Fiji, New Caledonia (France), and New Zealand.
‘ Panel D includes proportion of
specimens positive for influenza for all four countries, but ILI ratios only for Australia.
doi:10.1371/journal.pone.0037568.g003
Seasonal Influenza in the Western Pacific Region
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37568Figure 4. Number of influenza viruses by type/subtype and proportion of specimens positive for influenza in Western Pacific
Region countries, 2006–2010.*
‘ * Panel A: Mongolia and Republic of Korea; Panel B: China; Panel C: Cambodia, Lao PDR, Malaysia, Philippines,
Singapore, Viet Nam; and Panel D: Australia, Fiji, New Caledonia (France), New Zealand.
‘ The number of reported A(H1N1)pdm09 viruses was very
high compared to other subtypes/lineages. Thus, to better illustrate the patterns for other subtypes/lineages, the A(H1N1)pdm09 numbers were
divided by five.
doi:10.1371/journal.pone.0037568.g004
Seasonal Influenza in the Western Pacific Region
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study.
Conclusions and Way Forward
This collaborative effort to summarize epidemiological and
virological characteristics of influenza adds to the body of
knowledge on influenza in the Western Pacific Region. This study
highlights the progress made in influenza surveillance capacity in
countries of the Western Pacific Region between 2006 and 2010.
Epidemiological and virological characteristics of influenza
appeared to be interrelated across countries, underscoring the
importance of information-sharing and collaboration. However, it
is clear that variations in data collection, case definitions and
testing procedures currently limit comparisons.
Regional strategies have been developed to further strengthen
influenza surveillance and research in the region and address the
current limitations in cross-region analysis [18]. Countries and
areas are encouraged to develop detailed workplans and monitor
progress in three areas of work: (1) defining the epidemiology and
burden of influenza; (2) improving virological testing capacity; and
(3) improving communication and reporting through the devel-
opment or strengthening of regional and global networks.
Through implementation of workplans to strengthen influenza
surveillance, conduct of the research agenda and regular
information-sharing about epidemiological findings, policy makers
in the Western Pacific Region will be able to refine their policies
and enhance influenza control based on a solid foundation of
knowledge of the burden and characteristics of influenza virus
infection in their own and neighbouring countries.
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